Tag: Cerenovus

Advanced engineering improves rates of revascularisation through the first-pass effect

Advertorial In acute ischaemic stroke, fast and complete recanalisation of the occluded vessel is associated with improved outcomes. While morbidity and mortality in these patients...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed...

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...

First intracranial aneurysm patients treated with BRAVO Flow Diverter

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

First pass effect…always the goal!

Ischaemic stroke is as quick as it is destructive; minutes, even seconds can be the difference between patients returning to a healthy life or a hindered one....

Cerenovus receives US FDA clearance for next generation stent retriever device...

Cerenovus has announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for EMBOTRAP II revascularisation device, a next generation...

Cerenovus launches next generation embolic coil for treatment of cerebral aneurysms...

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced the launch of the Galaxy G3 mini coil, its smallest and softest...

Real-life use of EmboTrap shows comparable outcomes to large stroke studies

The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...

Cerenovus launches in Europe

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual...

Cerenovus introduced at SNIS

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...